Unknown file type. Enclosure URL IS: - http://radioactivebroadcasting.sbc-inc.net//directory-page/item/download/2473_9efe169e3953779de93501586743ffed
Summary: Hagop M. Kantarjian, M.D., is a nonresident fellow in health policy. He serves as a professor and chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, where he is also the Kelcie Margaret Kana Research Chair and associate vice president for global academic programs. As a clinical-translational researcher, Kantarjian has contributed to significant improvements in the treatment of various leukemias, including the development and testing of first- and second-generation BCR-ABL inhibitors in chronic myeloid leukemia, combination therapies for acute lymphocytic leukemia, and several new treatments for acute myeloid leukemia and myelodysplastic syndrome.SOFA_with_Hagop_M._Kantarjian.mp3
